CD226 and neoplasm: Similarly, CD155-expressing hepatocellular carcinoma cells induce CD226 downregulation, impairing CD226-mediated cytotoxicity in both tumor-infiltrating and circulating NK cells, which contributes to the tumor evasion of innate immune surveillance [61].